Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Al-Anazi Khalid Ahmed"'
Autor:
Al-Anazi Khalid Ahmed, A Alshami, E Mutahar, O Abduljalil, S Kanfer, P Kaloyannidis, J Bacal, A Estanislao, I Apostolidis, N Almokhtar, M Darweesh, M Abdulbaqi, W Alenazi, Z Alshammasi, O Albanyan, A Ayyad, Z Alsomali, M Albatran, H Raslan, A Albahrani, A Alsaber, N AlMulhem, W Dridi, R Alrabeh, F Abu Rahma, F Nightingale, P Ahadai, H Alhashmi
Publikováno v:
Journal of Stem Cell Therapy and Transplantation. 7:003-015
Background: Autologous hematopoietic stem cell transplants (HSCT) is the standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (MM) and patients with relapsed and refractory Hodgkin lymphoma (R/R-HL) who achieve chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf060816756283952a2144cef924ee14
https://doi.org/10.29328/journal.jsctt.1001030
https://doi.org/10.29328/journal.jsctt.1001030
Autor:
Al-Anazi Khalid Ahmed, E Mutahar, O Abduljalil, S Kanfer, P Kaloyannidis, A Estanislao, I Apostolidis, N Almokhtar, M Darweesh, M Abdulbaqi, W Alenazi, Z Alshammasi, Z Alshaibani, M Kawarie, H Raslan, A Albahrani, A Alsaber, N AlMulhem, W Dridi, A Aldayel, R Alrabeh, A Alshami, A Ayyad, F Abu Rahma, J Lardizabal, A Salam, K Haque, A Alsagheir, H Alhashmi
Publikováno v:
Journal of Stem Cell Therapy and Transplantation. 6:019-028
Background: Aautologous hematopoietic stem cell transplants (HSCT) is the standard of care for newly diagnosed patients with multiple myeloma (MM) who are eligible for autologous transplantation. Although cryopreservation is routinely employed, autol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9700601446007bf0185ac43f9a208958
https://doi.org/10.29328/journal.jsctt.1001027
https://doi.org/10.29328/journal.jsctt.1001027
Autor:
Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Mashhour, Miral, Gamil, Mohammed, Apostolidis, Ioannis, Al Hashmi, Hani, Al Anazi, Khalid Ahmed
Publikováno v:
Case Reports in Hematology.
The programmed cell death protein-1 (PD-1) inhibitor nivolumab has been recently approved as an effective and safe treatment for patients with refractory/relapsed Hodgkin’s lymphomas. Dermatological adverse events, mainly skin rash, have been repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=hindawi_publ::190af93f6bc7677b87c2b76ea57d2144
Autor:
Al-Anazi, Khalid Ahmed1 kaa_alanazi@yahoo.com, Abdalhamid, Baha2, Alshibani, Zeyad1, Awad, Khalid1, Alzayed, Abdullah1, Hassan, Hoda2, Alsayiegh, Mohammed1
Publikováno v:
Case Reports in Transplantation. 2012, p1-5. 5p.
Autor:
Al-Anazi, Khalid Ahmed1 kaa_alanazi@yahoo.com
Publikováno v:
Bone Marrow Research. 2012, p1-7. 7p.
Autor:
Al-Anazi, Khalid Ahmed1 khalid_alanazi@yahoo.com, Al-Jasser, Asma Marzouq2, Evans, David Alan Price3, Daff, Nasr Abu4
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Jun2006, Vol. 2 Issue 2, p91-97. 7p. 4 Charts, 2 Graphs.
Autor:
Al-Anazi, Khalid Ahmed1 khalid_alanazi@yahoo.com, Al-Omar, Hamad M.1, Al-Shanqeeti, Ali S.1, Al-Mubaraki, Abdullah2, Al-Sultan, Osama1, Mourad, Walid A.3
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Jun2006, Vol. 2 Issue 2, p109-113. 5p. 2 Color Photographs, 1 Black and White Photograph.
Autor:
Al-Anazi, Khalid Ahmed1 khalid_alanazi@yahoo.com, Al-Jasser, Asma Marzouq2, Evans, David Alan Price3
Publikováno v:
European Journal of Haematology. Sep2005, Vol. 75 Issue 3, p234-240. 7p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.